Abstract
There are several published methods for culturing human cells including chondrocytes, osteocytes, and tenocytes to study musculoskeletal development, disorders, and for tissue engineering [1–8]. In this chapter we will focus on cell culture approaches used for articular cartilage repair. Articular cartilage defects are found in nearly 60% of knee arthroscopies [9, 10]. Many times these defects are painful and may result in loss of function. Articular cartilage lacks a blood supply and innervation and therefore has a limited capacity to heal itself. Untreated chondral defects may lead to a cycle of cartilage degradation and eventual osteoarthritis. The goals of cartilage repair are to restore smooth articular cartilage surface, relieve patient symptoms, and improve function. Nonsurgical options available for treating cartilage defects include debridement and lavage. First-line surgical treatment options include bone marrow stimulation techniques such as microfracture, abrasion arthroplasty, and subchondral drilling. Other treatment options include osteochondral autografts and allografts or autologous chondrocyte implantation (ACI). ACI uses autologous cell culture-expanded chondrocytes for the repair of cartilage defects. ACI is the only cell therapy approved for cartilage repair in the USA. The technique was first described by Peterson, Lindahl, and Brittberg in 1987 [11]. It is a two-step procedure involving the harvest of cartilage from a non-weight-bearing location, in vitro expansion of chondrocytes, and reimplantation into the cartilage defect covered by a periosteal graft or off the shelf membrane. Mesenchymal stem cells (MSCs) are multipotent cells with enhanced proliferative capabilities that provide an attractive alternative source of cells for cartilage repair and other orthopedic applications. Cultured MSCs have been successfully used to treat cartilage defects. As an emerging technology, MSCs do not have as extensive a body of evidence as ACI, but clinical reports showing positive outcomes and ongoing clinical trials are advancing the field.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Tubo R, Binette F. Culture and identification of autologous human articular chondrocytes for implantation. Methods Mol Med. 1999;18:205–15.
Nakano N, et al. Age-dependent healing potential of anterior cruciate ligament remnant-derived cells. Am J Sports Med. 2015;43(3):700–8.
Andia I, Maffulli N. Biological therapies in regenerative sports medicine. Sports Med. 2016.
Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem. 1994;56(3):283–94.
Shah KM, et al. Osteocyte isolation and culture methods. Bonekey Rep. 2016;5:838.
Cody JJ, et al. A simplified method for the generation of human osteoclasts in vitro. Int J Biochem Mol Biol. 2011;2(2):183–9.
Gupta A, et al. Surgical retrieval, isolation and in vitro expansion of human anterior cruciate ligament-derived cells for tissue engineering applications. J Vis Exp. 2014;(86):51597.
Mifune Y, et al. Therapeutic potential of anterior cruciate ligament-derived stem cells for anterior cruciate ligament reconstruction. Cell Transplant. 2012;21(8):1651–65.
Widuchowski W, Widuchowski J, Trzaska T. Articular cartilage defects: study of 25,124 knee arthroscopies. Knee. 2007;14(3):177–82.
Hjelle K, et al. Articular cartilage defects in 1,000 knee arthroscopies. Arthroscopy. 2002;18(7):730–4.
Brittberg M, et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994;331(14):889–95.
FDA. Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products; final rule. 2004 [cited 69 101]; 29785–834. http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/ActsRulesRegulations/TissueProposedFinalRules/default.htm
Sekiya EJ, et al. Establishing a stem cell culture laboratory for clinical trials. Rev Bras Hematol Hemoter. 2012;34(3):236–41.
Sensebe L, Gadelorge M, Fleury-Cappellesso S. Production of mesenchymal stromal/stem cells according to good manufacturing practices: a review. Stem Cell Res Ther. 2013;4(3):66.
Sophia Fox AJ, Bedi A, Rodeo SA. The basic science of articular cartilage: structure, composition, and function. Sports Health. 2009;1(6):461–8.
Zhou S, Cui Z, Urban JP. Factors influencing the oxygen concentration gradient from the synovial surface of articular cartilage to the cartilage-bone interface: a modeling study. Arthritis Rheum. 2004;50(12):3915–24.
Akkiraju H, Nohe A. Role of chondrocytes in cartilage formation, progression of osteoarthritis and cartilage regeneration. J Dev Biol. 2015;3(4):177.
Benya PD, Shaffer JD. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell. 1982;30(1):215–24.
Cheung HS, et al. New collagen markers of ‘derepression’ synthesized by rabbit articular chondrocytes in culture. Biochem Biophys Res Commun. 1976;68(4):1371–8.
Huang BJ, Hu JC, Athanasiou KA. Cell-based tissue engineering strategies used in the clinical repair of articular cartilage. Biomaterials. 2016;98:1–22.
Dell’Accio F, De Bari C, Luyten FP. Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. Arthritis Rheum. 2001;44(7):1608–19.
Lin Z, et al. Gene expression profiles of human chondrocytes during passaged monolayer cultivation. J Orthop Res. 2008;26(9):1230–7.
Bruckner P, et al. Induction and prevention of chondrocyte hypertrophy in culture. J Cell Biol. 1989;109(5):2537–45.
Bonaventure J, et al. Reexpression of cartilage-specific genes by dedifferentiated human articular chondrocytes cultured in alginate beads. Exp Cell Res. 1994;212(1):97–104.
Haudenschild DR, et al. Differential expression of multiple genes during articular chondrocyte redifferentiation. Anat Rec. 2001;263(1):91–8.
Binette F, et al. Expression of a stable articular cartilage phenotype without evidence of hypertrophy by adult human articular chondrocytes in vitro. J Orthop Res. 1998;16(2):207–16.
Yaeger PC, et al. Synergistic action of transforming growth factor-beta and insulin-like growth factor-I induces expression of type II collagen and aggrecan genes in adult human articular chondrocytes. Exp Cell Res. 1997;237(2):318–25.
Caron MM, et al. Redifferentiation of dedifferentiated human articular chondrocytes: comparison of 2D and 3D cultures. Osteoarthr Cartil. 2012;20(10):1170–8.
Benya PD, Padilla SR, Nimni ME. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell. 1978;15(4):1313–21.
Benya PD, Brown PD, Padilla SR. Microfilament modification by dihydrocytochalasin B causes retinoic acid-modulated chondrocytes to reexpress the differentiated collagen phenotype without a change in shape. J Cell Biol. 1988;106(1):161–70.
Tew SR, et al. Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes. Osteoarthr Cartil. 2005;13(1): 80–9.
Barbero A, et al. Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum. 2003;48(5):1315–25.
Thirion S, Berenbaum F. Culture and phenotyping of chondrocytes in primary culture. In: Sabatini M, Pastoureau P, De Ceuninck F, editors. Cartilage and osteoarthritis: volume 1: cellular and molecular tools. Totowa: Humana Press; 2004. p. 1–14.
Gharravi AM, Orazizadeh M, Hashemitabar M. Direct expansion of chondrocytes in a dynamic three-dimensional culture system: overcoming dedifferentiation effects in monolayer culture. Artif Organs. 2014;38(12):1053–8.
Melero-Martin JM, et al. Optimal in-vitro expansion of chondroprogenitor cells in monolayer culture. Biotechnol Bioeng. 2006;93(3):519–33.
Kielpinski G, et al. Roadmap to approval: use of an automated sterility test method as a lot release test for Carticel, autologous cultured chondrocytes. Cytotherapy. 2005;7(6):531–41.
Rapko S, et al. Identification of the chondrocyte lineage using microfibril-associated glycoprotein-2, a novel marker that distinguishes chondrocytes from synovial cells. Tissue Eng Part C Methods. 2010;16(6):1367–75.
Marlovits S, et al. Cartilage repair: generations of autologous chondrocyte transplantation. Eur J Radiol. 2006;57(1):24–31.
Vangsness Jr CT, Sternberg H, Harris L. Umbilical cord tissue offers the greatest number of harvestable mesenchymal stem cells for research and clinical application: a literature review of different harvest sites. Arthroscopy. 2015;31(9):1836–43.
Hass R, et al. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011;9:12.
Klingemann H, Matzilevich D, Marchand J. Mesenchymal stem cells—sources and clinical applications. Transfus Med Hemother. 2008;35(4):272–7.
Murphy MB, Moncivais K, Caplan AI. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med. 2013;45:e54.
Dominici M, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7.
Jones BJ, McTaggart SJ. Immunosuppression by mesenchymal stromal cells: from culture to clinic. Exp Hematol. 2008;36(6):733–41.
Le Blanc K, et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol. 2003;57(1):11–20.
Iyer SS, Rojas M. Anti-inflammatory effects of mesenchymal stem cells: novel concept for future therapies. Expert Opin Biol Ther. 2008;8(5):569–81.
Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011;9(1):11–5.
Sorrell JM, Baber MA, Caplan AI. Influence of adult mesenchymal stem cells on in vitro vascular formation. Tissue Eng Part A. 2009;15(7):1751–61.
Krasnodembskaya A, et al. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells. 2010;28(12):2229–38.
de Girolamo L, et al. Treatment of chondral defects of the knee with one step matrix-assisted technique enhanced by autologous concentrated bone marrow: in vitro characterisation of mesenchymal stem cells from iliac crest and subchondral bone. Injury. 2010;41(11):1172–7.
Alvarez-Viejo M, et al. Quantifying mesenchymal stem cells in the mononuclear cell fraction of bone marrow samples obtained for cell therapy. Transplant Proc. 2013;45(1):434–9.
Pittenger MF, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–7.
Wagner W, et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One. 2008;3(5):e2213.
Bonab MM, et al. Aging of mesenchymal stem cell in vitro. BMC Cell Biol. 2006;7:14.
Izadpanah R, et al. Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res. 2008;68(11):4229–38.
Madeira A, et al. Human mesenchymal stem cell expression program upon extended ex-vivo cultivation, as revealed by 2-DE-based quantitative proteomics. PLoS One. 2012;7(8):e43523.
Halfon S, et al. Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev. 2011;20(1):53–66.
Bianchi G, et al. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res. 2003;287(1):98–105.
Johnstone B, et al. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998;238(1):265–72.
Mackay AM, et al. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng. 1998;4(4):415–28.
Auletta JJ, et al. Fibroblast growth factor-2 enhances expansion of human bone marrow-derived mesenchymal stromal cells without diminishing their immunosuppressive potential. Stem Cells Int. 2011;2011:235176.
Felka T, et al. Animal serum-free expansion and differentiation of human mesenchymal stromal cells. Cytotherapy. 2010;12(2):143–53.
Grigolo B, et al. Transplantation of chondrocytes seeded on a hyaluronan derivative (hyaff-11) into cartilage defects in rabbits. Biomaterials. 2001;22(17):2417–24.
Kavalkovich KW, et al. Chondrogenic differentiation of human mesenchymal stem cells within an alginate layer culture system. In Vitro Cell Dev Biol Anim. 2002;38(8):457–66.
Tuli R, Li WJ, Tuan RS. Current state of cartilage tissue engineering. Arthritis Res Ther. 2003;5(5):235–8.
Karlsson C, et al. Differentiation of human mesenchymal stem cells and articular chondrocytes: analysis of chondrogenic potential and expression pattern of differentiation-related transcription factors. J Orthop Res. 2007;25(2):152–63.
Williams R, et al. Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilage. PLoS One. 2010;5(10):e13246.
Giuliani N, et al. New insights into osteogenic and chondrogenic differentiation of human bone marrow mesenchymal stem cells and their potential clinical applications for bone regeneration in pediatric orthopaedics. Stem Cells Int. 2013;2013:312501.
Yang KG, et al. Impact of expansion and redifferentiation conditions on chondrogenic capacity of cultured chondrocytes. Tissue Eng. 2006;12(9):2435–47.
Itoh S, et al. Trps1 plays a pivotal role downstream of Gdf5 signaling in promoting chondrogenesis and apoptosis of ATDC5 cells. Genes Cells. 2008;13(4):355–63.
Leung VY, et al. SOX9 governs differentiation stage-specific gene expression in growth plate chondrocytes via direct concomitant transactivation and repression. PLoS Genet. 2011;7(11):e1002356.
Torreggiani E, et al. Role of slug transcription factor in human mesenchymal stem cells. J Cell Mol Med. 2012;16(4):740–51.
Barry F, et al. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res. 2001;268(2):189–200.
Schmitt B, et al. BMP2 initiates chondrogenic lineage development of adult human mesenchymal stem cells in high-density culture. Differentiation. 2003;71(9–10):567–77.
Sekiya I, Colter DC, Prockop DJ. BMP-6 enhances chondrogenesis in a subpopulation of human marrow stromal cells. Biochem Biophys Res Commun. 2001;284(2):411–8.
Sekiya I, et al. Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell Tissue Res. 2005;320(2):269–76.
Potier E, Noailly J, Ito K. Directing bone marrow-derived stromal cell function with mechanics. J Biomech. 2010;43(5):807–17.
Araldi E, Schipani E. Hypoxia, HIFs and bone development. Bone. 2010;47(2):190–6.
Khan WS, et al. Bone marrow-derived mesenchymal stem cells express the pericyte marker 3G5 in culture and show enhanced chondrogenesis in hypoxic conditions. J Orthop Res. 2010;28(6):834–40.
Murdoch AD, et al. Chondrogenic differentiation of human bone marrow stem cells in transwell cultures: generation of scaffold-free cartilage. Stem Cells. 2007;25(11):2786–96.
Shirasawa S, et al. In vitro chondrogenesis of human synovium-derived mesenchymal stem cells: optimal condition and comparison with bone marrow-derived cells. J Cell Biochem. 2006;97(1):84–97.
Dickhut A, et al. Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage. J Cell Physiol. 2009;219(1):219–26.
Wakitani S, et al. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthr Cartil. 2002;10(3):199–206.
Wakitani S, et al. Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transplant. 2004;13(5):595–600.
Wakitani S, et al. Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees. J Tissue Eng Regen Med. 2007;1(1):74–9.
Nejadnik H, et al. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med. 2010;38(6):1110–6.
Akgun I, et al. Matrix-induced autologous mesenchymal stem cell implantation versus matrix-induced autologous chondrocyte implantation in the treatment of chondral defects of the knee: a 2-year randomized study. Arch Orthop Trauma Surg. 2015;135(2):251–63.
Sekiya I, et al. Arthroscopic transplantation of synovial stem cells improves clinical outcomes in knees with cartilage defects. Clin Orthop Relat Res. 2015;473(7):2316–26.
Bekkers JE, et al. One-stage focal cartilage defect treatment with bone marrow mononuclear cells and chondrocytes leads to better macroscopic cartilage regeneration compared to microfracture in goats. Osteoarthr Cartil. 2013;21(7):950–6.
Bekkers JE, et al. Single-stage cell-based cartilage regeneration using a combination of chondrons and mesenchymal stromal cells: comparison with microfracture. Am J Sports Med. 2013;41(9):2158–66.
Vonk LA, et al. Preservation of the chondrocyte’s pericellular matrix improves cell-induced cartilage formation. J Cell Biochem. 2010;110(1):260–71.
Bomer N, et al. Neo-cartilage engineered from primary chondrocytes is epigenetically similar to autologous cartilage, in contrast to using mesenchymal stem cells. Osteoarthr Cartil. 2016;24(8):1423–30.
Garcia J, et al. Chondrogenic potency analyses of donor-matched chondrocytes and mesenchymal stem cells derived from bone marrow, infrapatellar fat pad, and subcutaneous fat. Stem Cells Int. 2016;2016:6969726.
Li S, et al. Chondrogenic potential of human articular chondrocytes and skeletal stem cells: a comparative study. J Biomater Appl. 2015;29(6):824–36.
Gurusinghe S, Strappe P. Gene modification of mesenchymal stem cells and articular chondrocytes to enhance chondrogenesis. Biomed Res Int. 2014;2014:369528.
Ding Q, et al. A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell. 2013;12(2):238–51.
Cong L, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339(6121):819–23.
Mali P, et al. RNA-guided human genome engineering via Cas9. Science. 2013;339(6121):823–6.
Ran FA, et al. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8(11):2281–308.
Jinek M, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816–21.
Tsumaki N, Okada M, Yamashita A. iPS cell technologies and cartilage regeneration. Bone. 2015;70:48–54.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 ISAKOS
About this chapter
Cite this chapter
Fakunle, E.S., Lane, J.G. (2017). Cell Culture Approaches for Articular Cartilage: Repair and Regeneration. In: Gobbi, A., Espregueira-Mendes, J., Lane, J., Karahan, M. (eds) Bio-orthopaedics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54181-4_13
Download citation
DOI: https://doi.org/10.1007/978-3-662-54181-4_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-54180-7
Online ISBN: 978-3-662-54181-4
eBook Packages: MedicineMedicine (R0)